Poongsan Corporation (KRX:103140)

Market Cap	4.39T
Revenue (ttm)	4.75T
Net Income (ttm)	240.71B
Shares Out	27.31M
EPS (ttm)	8,812.70
PE Ratio	18.25
Forward PE	17.81
Dividend	2,600.00 (1.63%)
Ex-Dividend Date	Feb 27, 2025

Volume	456,782
Average Volume	530,684
Open	154,900
Previous Close	159,700
Day's Range	152,100 - 164,000
52-Week Range	46,150 - 172,200
Beta	1.36
RSI	65.75
Earnings Date	Aug 7, 2025

About Checkpoint Therapeutics

Poongsan Corporation develops, manufactures, markets, exports, and sells fabricated non-ferrous metal, commercial ammunition, and defense products in South Korea and internationally. It offers copper and copper alloy sheets, strips, rods, bars, and wires, as well as thin plates, thin tubes, bimetal sinters, and coin blanks; leadframe materials; stainless steel strips; and tin-plated strips and precision forgings, as well as copper roofing materials. The company’s copper and copper alloy sheets and strips are used for interior and exterior appli...

• Industry: Metal Fabrication
• Sector: Industrials
• Founded: 1968
• Employees: 2,711
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 103140

Financial Performance

In 2024, Poongsan's revenue was 4.55 trillion, an increase of 10.40% compared to the previous year's 4.13 trillion. Earnings were 236.05 billion, an increase of 50.89%.